Review



app ps1 ki mice  (Oxford Instruments)


Bioz Verified Symbol Oxford Instruments is a verified supplier
Bioz Manufacturer Symbol Oxford Instruments manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Oxford Instruments app ps1 ki mice
    Selective attenuation of proinflammatory cytokines by MW150 administration in <t>APP/PS1</t> KI mice cortex. a 11–12-month-old wild type ( WT ) or APP/PS1 knock-in ( KI ) mice were treated with saline vehicle ( veh ) or 2.5 mg/kg MW150 by intraperitoneal injection (i.p.) once daily for 14 days. b IL-1β was increased in KI + veh mice compared to WT + veh mice ( p = 0.0012), and MW150 treatment of KI mice (KI + MW150) significantly attenuated IL-1β levels compared to KI + veh ( p = 0.0243) ( F (2,38) = 6.46; p = 0.004). c TNFα was elevated in KI + veh mice compared to WT + veh and attenuated in KI + MW150 mice compared to KI + veh; however, these changes were not significant ( F (2,38) = 1.11; p = 0.34). d IL-6 was slightly elevated in KI + veh compared to WT + veh mice, and there was no effect of MW150 treatment ( n = 11 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S1
    App Ps1 Ki Mice, supplied by Oxford Instruments, used in various techniques. Bioz Stars score: 99/100, based on 43904 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/app+ps1+ki+mice/pmc05382362-147-20-27?v=Oxford+Instruments
    Average 99 stars, based on 43904 article reviews
    app ps1 ki mice - by Bioz Stars, 2026-08
    99/100 stars

    Images

    1) Product Images from "Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes"

    Article Title: Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes

    Journal: Journal of Neuroinflammation

    doi: 10.1186/s12974-017-0845-2

    Selective attenuation of proinflammatory cytokines by MW150 administration in APP/PS1 KI mice cortex. a 11–12-month-old wild type ( WT ) or APP/PS1 knock-in ( KI ) mice were treated with saline vehicle ( veh ) or 2.5 mg/kg MW150 by intraperitoneal injection (i.p.) once daily for 14 days. b IL-1β was increased in KI + veh mice compared to WT + veh mice ( p = 0.0012), and MW150 treatment of KI mice (KI + MW150) significantly attenuated IL-1β levels compared to KI + veh ( p = 0.0243) ( F (2,38) = 6.46; p = 0.004). c TNFα was elevated in KI + veh mice compared to WT + veh and attenuated in KI + MW150 mice compared to KI + veh; however, these changes were not significant ( F (2,38) = 1.11; p = 0.34). d IL-6 was slightly elevated in KI + veh compared to WT + veh mice, and there was no effect of MW150 treatment ( n = 11 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S1
    Figure Legend Snippet: Selective attenuation of proinflammatory cytokines by MW150 administration in APP/PS1 KI mice cortex. a 11–12-month-old wild type ( WT ) or APP/PS1 knock-in ( KI ) mice were treated with saline vehicle ( veh ) or 2.5 mg/kg MW150 by intraperitoneal injection (i.p.) once daily for 14 days. b IL-1β was increased in KI + veh mice compared to WT + veh mice ( p = 0.0012), and MW150 treatment of KI mice (KI + MW150) significantly attenuated IL-1β levels compared to KI + veh ( p = 0.0243) ( F (2,38) = 6.46; p = 0.004). c TNFα was elevated in KI + veh mice compared to WT + veh and attenuated in KI + MW150 mice compared to KI + veh; however, these changes were not significant ( F (2,38) = 1.11; p = 0.34). d IL-6 was slightly elevated in KI + veh compared to WT + veh mice, and there was no effect of MW150 treatment ( n = 11 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S1

    Techniques Used: Knock-In, Saline, Injection

    No effect of MW150 on GFAP immunostaining. a Representative images of GFAP immunohistochemical (IHC) staining in cortex of WT or APP/PS1 KI mice treated with vehicle ( veh ) or MW150. b Digital quantification of GFAP in the cortex was done using the Aperio ScanScope with the entire cortex used as the region of interest. Quantification using the positive pixel algorithm showed a significant increase in GFAP staining in the KI + veh compared to WT + veh ( p < 0.0001). No significant difference was found between the KI + veh compared to the KI + MW150. (F2,41) = 34.66; p < 0.0001). ( n = 14 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S2
    Figure Legend Snippet: No effect of MW150 on GFAP immunostaining. a Representative images of GFAP immunohistochemical (IHC) staining in cortex of WT or APP/PS1 KI mice treated with vehicle ( veh ) or MW150. b Digital quantification of GFAP in the cortex was done using the Aperio ScanScope with the entire cortex used as the region of interest. Quantification using the positive pixel algorithm showed a significant increase in GFAP staining in the KI + veh compared to WT + veh ( p < 0.0001). No significant difference was found between the KI + veh compared to the KI + MW150. (F2,41) = 34.66; p < 0.0001). ( n = 14 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S2

    Techniques Used: Immunostaining, Immunohistochemical staining, Immunohistochemistry, Staining

    No effect of MW150 on IBA1 + microglia volume. a Representative 3D surface reconstructions of IBA1 + cells generated from confocal microscopic imaging using Imaris software. b Mean volume ± standard deviation (SD) of rendered IBA1 cells is shown for the APP/PS1 KI + veh and APP/PS1 KI + MW150 groups. Data represent mean of 3–4 independent z-stacks from each mouse. ( n = 11 KI + veh; n = 14 KI + MW150)
    Figure Legend Snippet: No effect of MW150 on IBA1 + microglia volume. a Representative 3D surface reconstructions of IBA1 + cells generated from confocal microscopic imaging using Imaris software. b Mean volume ± standard deviation (SD) of rendered IBA1 cells is shown for the APP/PS1 KI + veh and APP/PS1 KI + MW150 groups. Data represent mean of 3–4 independent z-stacks from each mouse. ( n = 11 KI + veh; n = 14 KI + MW150)

    Techniques Used: Generated, Imaging, Software, Standard Deviation

    No effect of MW150 on CD45 and CD68 immunostaining in the cortex. a Representative images of CD45 IHC in cortex of wild type ( WT ) or APP/PS1 KI mice treated with saline vehicle ( veh ) or MW150. Digital quantification of CD45 in the cortex was done using the Aperio ScanScope, and the positive pixel algorithm. b CD45 was significantly increased in the KI + veh compared to the WT + veh treated mice ( p < 0.0001), with no effect of MW150 treatment. ( F (2,42) = 211.08; p < 0.0001). c Representative images of CD68 IHC. d CD68 was significantly increased in the KI + veh compared to the WT + veh-treated mice ( p < 0.0001), with no effect of MW150 treatment. ( F (2,42) = 28.81; p < 0.0001). ( n = 14 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S2
    Figure Legend Snippet: No effect of MW150 on CD45 and CD68 immunostaining in the cortex. a Representative images of CD45 IHC in cortex of wild type ( WT ) or APP/PS1 KI mice treated with saline vehicle ( veh ) or MW150. Digital quantification of CD45 in the cortex was done using the Aperio ScanScope, and the positive pixel algorithm. b CD45 was significantly increased in the KI + veh compared to the WT + veh treated mice ( p < 0.0001), with no effect of MW150 treatment. ( F (2,42) = 211.08; p < 0.0001). c Representative images of CD68 IHC. d CD68 was significantly increased in the KI + veh compared to the WT + veh-treated mice ( p < 0.0001), with no effect of MW150 treatment. ( F (2,42) = 28.81; p < 0.0001). ( n = 14 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S2

    Techniques Used: Immunostaining, Saline

    Effect of MW150 treatment on microglia closely associated with Aβ plaques and microglia-internalized Aβ in the cortex of APP/PS1 KI mice. a Representative images of Imaris 3D reconstruction of plaques. A region of interest ( ROI ) was generated by expanding the plaque volume by a 15 μm radius from the edge of the large plaques (larger than 10,000 voxels). This 3D ROI (shown in gray ) included the Aβ plaque, and a region near the plaque. IBA1 + cells in this ROI (shown in cyan ) were surface rendered to create a 3D volume of all IBA1 positive staining in the ROI. The IBA1 positive staining in the 3D ROI distinguishes plaque-associated microglia (shown in cyan ) compared to microglia away from plaques (shown in green ). b Volume of surface rendered IBA1 + cells within 15 μm radius around large plaques was significantly increased in KI + MW150 mice compared to KI + veh treatment ( p = 0.0397). c Representative image of microglia reconstruction with DAPI stained nuclei showing 6E10 staining within IBA1 + cell cytoplasm. d Microglia-internalized Aβ, as measured by 6E10 staining within surface rendered IBA1 + cells, was not significantly different between the KI + MW150 compared to KI + veh. ( n = 11 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S3
    Figure Legend Snippet: Effect of MW150 treatment on microglia closely associated with Aβ plaques and microglia-internalized Aβ in the cortex of APP/PS1 KI mice. a Representative images of Imaris 3D reconstruction of plaques. A region of interest ( ROI ) was generated by expanding the plaque volume by a 15 μm radius from the edge of the large plaques (larger than 10,000 voxels). This 3D ROI (shown in gray ) included the Aβ plaque, and a region near the plaque. IBA1 + cells in this ROI (shown in cyan ) were surface rendered to create a 3D volume of all IBA1 positive staining in the ROI. The IBA1 positive staining in the 3D ROI distinguishes plaque-associated microglia (shown in cyan ) compared to microglia away from plaques (shown in green ). b Volume of surface rendered IBA1 + cells within 15 μm radius around large plaques was significantly increased in KI + MW150 mice compared to KI + veh treatment ( p = 0.0397). c Representative image of microglia reconstruction with DAPI stained nuclei showing 6E10 staining within IBA1 + cell cytoplasm. d Microglia-internalized Aβ, as measured by 6E10 staining within surface rendered IBA1 + cells, was not significantly different between the KI + MW150 compared to KI + veh. ( n = 11 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S3

    Techniques Used: Generated, Staining



    Similar Products

    99
    Oxford Instruments app ps1 ki mice
    Selective attenuation of proinflammatory cytokines by MW150 administration in <t>APP/PS1</t> KI mice cortex. a 11–12-month-old wild type ( WT ) or APP/PS1 knock-in ( KI ) mice were treated with saline vehicle ( veh ) or 2.5 mg/kg MW150 by intraperitoneal injection (i.p.) once daily for 14 days. b IL-1β was increased in KI + veh mice compared to WT + veh mice ( p = 0.0012), and MW150 treatment of KI mice (KI + MW150) significantly attenuated IL-1β levels compared to KI + veh ( p = 0.0243) ( F (2,38) = 6.46; p = 0.004). c TNFα was elevated in KI + veh mice compared to WT + veh and attenuated in KI + MW150 mice compared to KI + veh; however, these changes were not significant ( F (2,38) = 1.11; p = 0.34). d IL-6 was slightly elevated in KI + veh compared to WT + veh mice, and there was no effect of MW150 treatment ( n = 11 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S1
    App Ps1 Ki Mice, supplied by Oxford Instruments, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/app+ps1+ki+mice/pmc05382362-147-20-27?v=Oxford+Instruments
    Average 99 stars, based on 1 article reviews
    app ps1 ki mice - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    90
    Sanofi brains homogenates of 9‐month‐old transgenic mice app/ps1 ki
    Selective attenuation of proinflammatory cytokines by MW150 administration in <t>APP/PS1</t> KI mice cortex. a 11–12-month-old wild type ( WT ) or APP/PS1 knock-in ( KI ) mice were treated with saline vehicle ( veh ) or 2.5 mg/kg MW150 by intraperitoneal injection (i.p.) once daily for 14 days. b IL-1β was increased in KI + veh mice compared to WT + veh mice ( p = 0.0012), and MW150 treatment of KI mice (KI + MW150) significantly attenuated IL-1β levels compared to KI + veh ( p = 0.0243) ( F (2,38) = 6.46; p = 0.004). c TNFα was elevated in KI + veh mice compared to WT + veh and attenuated in KI + MW150 mice compared to KI + veh; however, these changes were not significant ( F (2,38) = 1.11; p = 0.34). d IL-6 was slightly elevated in KI + veh compared to WT + veh mice, and there was no effect of MW150 treatment ( n = 11 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S1
    Brains Homogenates Of 9‐Month‐Old Transgenic Mice App/Ps1 Ki, supplied by Sanofi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/app+ps1+ki+mice/pmc08029131-118-0-18?v=Sanofi
    Average 90 stars, based on 1 article reviews
    brains homogenates of 9‐month‐old transgenic mice app/ps1 ki - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Sanofi female app sl ps1 ki mice
    Selective attenuation of proinflammatory cytokines by MW150 administration in <t>APP/PS1</t> KI mice cortex. a 11–12-month-old wild type ( WT ) or APP/PS1 knock-in ( KI ) mice were treated with saline vehicle ( veh ) or 2.5 mg/kg MW150 by intraperitoneal injection (i.p.) once daily for 14 days. b IL-1β was increased in KI + veh mice compared to WT + veh mice ( p = 0.0012), and MW150 treatment of KI mice (KI + MW150) significantly attenuated IL-1β levels compared to KI + veh ( p = 0.0243) ( F (2,38) = 6.46; p = 0.004). c TNFα was elevated in KI + veh mice compared to WT + veh and attenuated in KI + MW150 mice compared to KI + veh; however, these changes were not significant ( F (2,38) = 1.11; p = 0.34). d IL-6 was slightly elevated in KI + veh compared to WT + veh mice, and there was no effect of MW150 treatment ( n = 11 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S1
    Female App Sl Ps1 Ki Mice, supplied by Sanofi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/app+ps1+ki+mice/pmc02801255-81-2-30?v=Sanofi
    Average 90 stars, based on 1 article reviews
    female app sl ps1 ki mice - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    Image Search Results


    Selective attenuation of proinflammatory cytokines by MW150 administration in APP/PS1 KI mice cortex. a 11–12-month-old wild type ( WT ) or APP/PS1 knock-in ( KI ) mice were treated with saline vehicle ( veh ) or 2.5 mg/kg MW150 by intraperitoneal injection (i.p.) once daily for 14 days. b IL-1β was increased in KI + veh mice compared to WT + veh mice ( p = 0.0012), and MW150 treatment of KI mice (KI + MW150) significantly attenuated IL-1β levels compared to KI + veh ( p = 0.0243) ( F (2,38) = 6.46; p = 0.004). c TNFα was elevated in KI + veh mice compared to WT + veh and attenuated in KI + MW150 mice compared to KI + veh; however, these changes were not significant ( F (2,38) = 1.11; p = 0.34). d IL-6 was slightly elevated in KI + veh compared to WT + veh mice, and there was no effect of MW150 treatment ( n = 11 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S1

    Journal: Journal of Neuroinflammation

    Article Title: Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes

    doi: 10.1186/s12974-017-0845-2

    Figure Lengend Snippet: Selective attenuation of proinflammatory cytokines by MW150 administration in APP/PS1 KI mice cortex. a 11–12-month-old wild type ( WT ) or APP/PS1 knock-in ( KI ) mice were treated with saline vehicle ( veh ) or 2.5 mg/kg MW150 by intraperitoneal injection (i.p.) once daily for 14 days. b IL-1β was increased in KI + veh mice compared to WT + veh mice ( p = 0.0012), and MW150 treatment of KI mice (KI + MW150) significantly attenuated IL-1β levels compared to KI + veh ( p = 0.0243) ( F (2,38) = 6.46; p = 0.004). c TNFα was elevated in KI + veh mice compared to WT + veh and attenuated in KI + MW150 mice compared to KI + veh; however, these changes were not significant ( F (2,38) = 1.11; p = 0.34). d IL-6 was slightly elevated in KI + veh compared to WT + veh mice, and there was no effect of MW150 treatment ( n = 11 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S1

    Article Snippet: Fig. 6 Effect of MW150 treatment on microglia closely associated with Aβ plaques and microglia-internalized Aβ in the cortex of APP/PS1 KI mice. a Representative images of Imaris 3D reconstruction of plaques.

    Techniques: Knock-In, Saline, Injection

    No effect of MW150 on GFAP immunostaining. a Representative images of GFAP immunohistochemical (IHC) staining in cortex of WT or APP/PS1 KI mice treated with vehicle ( veh ) or MW150. b Digital quantification of GFAP in the cortex was done using the Aperio ScanScope with the entire cortex used as the region of interest. Quantification using the positive pixel algorithm showed a significant increase in GFAP staining in the KI + veh compared to WT + veh ( p < 0.0001). No significant difference was found between the KI + veh compared to the KI + MW150. (F2,41) = 34.66; p < 0.0001). ( n = 14 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S2

    Journal: Journal of Neuroinflammation

    Article Title: Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes

    doi: 10.1186/s12974-017-0845-2

    Figure Lengend Snippet: No effect of MW150 on GFAP immunostaining. a Representative images of GFAP immunohistochemical (IHC) staining in cortex of WT or APP/PS1 KI mice treated with vehicle ( veh ) or MW150. b Digital quantification of GFAP in the cortex was done using the Aperio ScanScope with the entire cortex used as the region of interest. Quantification using the positive pixel algorithm showed a significant increase in GFAP staining in the KI + veh compared to WT + veh ( p < 0.0001). No significant difference was found between the KI + veh compared to the KI + MW150. (F2,41) = 34.66; p < 0.0001). ( n = 14 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S2

    Article Snippet: Fig. 6 Effect of MW150 treatment on microglia closely associated with Aβ plaques and microglia-internalized Aβ in the cortex of APP/PS1 KI mice. a Representative images of Imaris 3D reconstruction of plaques.

    Techniques: Immunostaining, Immunohistochemical staining, Immunohistochemistry, Staining

    No effect of MW150 on IBA1 + microglia volume. a Representative 3D surface reconstructions of IBA1 + cells generated from confocal microscopic imaging using Imaris software. b Mean volume ± standard deviation (SD) of rendered IBA1 cells is shown for the APP/PS1 KI + veh and APP/PS1 KI + MW150 groups. Data represent mean of 3–4 independent z-stacks from each mouse. ( n = 11 KI + veh; n = 14 KI + MW150)

    Journal: Journal of Neuroinflammation

    Article Title: Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes

    doi: 10.1186/s12974-017-0845-2

    Figure Lengend Snippet: No effect of MW150 on IBA1 + microglia volume. a Representative 3D surface reconstructions of IBA1 + cells generated from confocal microscopic imaging using Imaris software. b Mean volume ± standard deviation (SD) of rendered IBA1 cells is shown for the APP/PS1 KI + veh and APP/PS1 KI + MW150 groups. Data represent mean of 3–4 independent z-stacks from each mouse. ( n = 11 KI + veh; n = 14 KI + MW150)

    Article Snippet: Fig. 6 Effect of MW150 treatment on microglia closely associated with Aβ plaques and microglia-internalized Aβ in the cortex of APP/PS1 KI mice. a Representative images of Imaris 3D reconstruction of plaques.

    Techniques: Generated, Imaging, Software, Standard Deviation

    No effect of MW150 on CD45 and CD68 immunostaining in the cortex. a Representative images of CD45 IHC in cortex of wild type ( WT ) or APP/PS1 KI mice treated with saline vehicle ( veh ) or MW150. Digital quantification of CD45 in the cortex was done using the Aperio ScanScope, and the positive pixel algorithm. b CD45 was significantly increased in the KI + veh compared to the WT + veh treated mice ( p < 0.0001), with no effect of MW150 treatment. ( F (2,42) = 211.08; p < 0.0001). c Representative images of CD68 IHC. d CD68 was significantly increased in the KI + veh compared to the WT + veh-treated mice ( p < 0.0001), with no effect of MW150 treatment. ( F (2,42) = 28.81; p < 0.0001). ( n = 14 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S2

    Journal: Journal of Neuroinflammation

    Article Title: Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes

    doi: 10.1186/s12974-017-0845-2

    Figure Lengend Snippet: No effect of MW150 on CD45 and CD68 immunostaining in the cortex. a Representative images of CD45 IHC in cortex of wild type ( WT ) or APP/PS1 KI mice treated with saline vehicle ( veh ) or MW150. Digital quantification of CD45 in the cortex was done using the Aperio ScanScope, and the positive pixel algorithm. b CD45 was significantly increased in the KI + veh compared to the WT + veh treated mice ( p < 0.0001), with no effect of MW150 treatment. ( F (2,42) = 211.08; p < 0.0001). c Representative images of CD68 IHC. d CD68 was significantly increased in the KI + veh compared to the WT + veh-treated mice ( p < 0.0001), with no effect of MW150 treatment. ( F (2,42) = 28.81; p < 0.0001). ( n = 14 WT + veh; n = 14 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S2

    Article Snippet: Fig. 6 Effect of MW150 treatment on microglia closely associated with Aβ plaques and microglia-internalized Aβ in the cortex of APP/PS1 KI mice. a Representative images of Imaris 3D reconstruction of plaques.

    Techniques: Immunostaining, Saline

    Effect of MW150 treatment on microglia closely associated with Aβ plaques and microglia-internalized Aβ in the cortex of APP/PS1 KI mice. a Representative images of Imaris 3D reconstruction of plaques. A region of interest ( ROI ) was generated by expanding the plaque volume by a 15 μm radius from the edge of the large plaques (larger than 10,000 voxels). This 3D ROI (shown in gray ) included the Aβ plaque, and a region near the plaque. IBA1 + cells in this ROI (shown in cyan ) were surface rendered to create a 3D volume of all IBA1 positive staining in the ROI. The IBA1 positive staining in the 3D ROI distinguishes plaque-associated microglia (shown in cyan ) compared to microglia away from plaques (shown in green ). b Volume of surface rendered IBA1 + cells within 15 μm radius around large plaques was significantly increased in KI + MW150 mice compared to KI + veh treatment ( p = 0.0397). c Representative image of microglia reconstruction with DAPI stained nuclei showing 6E10 staining within IBA1 + cell cytoplasm. d Microglia-internalized Aβ, as measured by 6E10 staining within surface rendered IBA1 + cells, was not significantly different between the KI + MW150 compared to KI + veh. ( n = 11 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S3

    Journal: Journal of Neuroinflammation

    Article Title: Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes

    doi: 10.1186/s12974-017-0845-2

    Figure Lengend Snippet: Effect of MW150 treatment on microglia closely associated with Aβ plaques and microglia-internalized Aβ in the cortex of APP/PS1 KI mice. a Representative images of Imaris 3D reconstruction of plaques. A region of interest ( ROI ) was generated by expanding the plaque volume by a 15 μm radius from the edge of the large plaques (larger than 10,000 voxels). This 3D ROI (shown in gray ) included the Aβ plaque, and a region near the plaque. IBA1 + cells in this ROI (shown in cyan ) were surface rendered to create a 3D volume of all IBA1 positive staining in the ROI. The IBA1 positive staining in the 3D ROI distinguishes plaque-associated microglia (shown in cyan ) compared to microglia away from plaques (shown in green ). b Volume of surface rendered IBA1 + cells within 15 μm radius around large plaques was significantly increased in KI + MW150 mice compared to KI + veh treatment ( p = 0.0397). c Representative image of microglia reconstruction with DAPI stained nuclei showing 6E10 staining within IBA1 + cell cytoplasm. d Microglia-internalized Aβ, as measured by 6E10 staining within surface rendered IBA1 + cells, was not significantly different between the KI + MW150 compared to KI + veh. ( n = 11 KI + veh; n = 14 KI + MW150). Data are mean ± SEM. Source data is available in Additional file : Table S3

    Article Snippet: Fig. 6 Effect of MW150 treatment on microglia closely associated with Aβ plaques and microglia-internalized Aβ in the cortex of APP/PS1 KI mice. a Representative images of Imaris 3D reconstruction of plaques.

    Techniques: Generated, Staining